Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101143863B details a novel resolution method for (6S)-5-MTHF using alpha-phenylethylamine, offering high purity and reduced chloride contamination for pharmaceutical manufacturing.
Novel reductive amination route for Rivastigmine intermediate CN101016257A. Enhances yield and purity for API manufacturing supply chains.
Novel enzymatic resolution and atmospheric coupling process for high-purity pharmaceutical intermediates ensuring cost reduction and supply reliability.
Patent CN104781243A details a novel chiral synthesis for ribonolactone intermediates. This report analyzes cost reduction and supply chain advantages for pharmaceutical manufacturing.
Novel patent CN109824547A enables safer synthesis of double protected amino acids. Achieve high purity and reduced costs for pharmaceutical intermediate manufacturing supply chains.
Patent CN112707901A reveals a cost-effective resolution method for moxifloxacin side chains using gulonic acid, offering >98% ee and simplified manufacturing for reliable API intermediate supply.
Patent CN103755624A reveals a novel synthesis method for piperidine derivatives, significantly improving yield and purity for Tofacitinib manufacturing while reducing costs.
Patent CN101448838B details a novel catalytic route for HIV protease inhibitor intermediates, offering significant cost reduction and improved supply chain reliability for antiviral manufacturing.
Patent CN106632368A reveals a scalable total synthesis route for Irinotecan Hydrochloride, ensuring high purity and supply chain stability for global API manufacturers.
Novel nickel-catalyzed hydrogenation and lipase resolution method for high-purity 1-acenaphthenol. Enhances safety and yield for global pharmaceutical supply chains effectively.
Novel chemical synthesis of L-norvaline from n-butyraldehyde offers cost-effective, scalable production for Perindopril intermediates, surpassing traditional fermentation limits.
Novel enzymatic and cobalt-catalyzed route for antiviral intermediate. Reduces toxicity, improves safety, ensures reliable supply chain for pharmaceutical manufacturing.
Patent CN102212081B details a novel asymmetric synthesis for statin side chains, offering high purity and eliminating resolution steps for cost-effective manufacturing.
Novel resolution method for argatroban starting material improves purity and yield. Offers supply chain stability and cost efficiency for pharmaceutical manufacturing.
Patent CN100341850C details a novel chiral resolution method for demethylphencynonate salts, enabling >98% optical purity for anti-motion sickness API manufacturing with reduced costs.
Patent CN1293039C reveals a superior method for [(S)-(-)-alpha-methylamino phenylketone]2.(2R,3R)-tartaric acid derivative synthesis, offering enhanced yield and purity for ephedrine production.
Patent CN1100410A details a novel route for (+)-2-(3,4-dichlorophenyl)-4-hydroxybutylamine using N-methylglucamine resolution and borane reduction for high-purity tachykinin antagonists.
Advanced enzymatic and chemical separation process for high-purity escitalopram intermediates. Reduces manufacturing costs and improves supply chain reliability for global API producers.
Patent CN101547893B reveals a novel salt recovery method for biphenylalanine, enabling cost reduction in pharmaceutical intermediate manufacturing through direct extraction and recycling.
Patent CN101514163A reveals high-efficiency chiral resolution for Sibutramine. Offers supply chain stability and cost reduction for pharmaceutical intermediates.